Inventor
YEUNG KAP-SUN
US54 patents
⚠️ This page may combine multiple inventors who share the name “YEUNG KAP-SUN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
38 patentsUS7745625B2Jun 29, 2010
Prodrugs of piperazine and substituted piperidine antiviral agents
BRISTOL MYERS SQUIBB CO62 citations97
US9308236B2Apr 12, 2016
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
BRISTOL MYERS SQUIBB CO51 citations96
US6469006B1Oct 22, 2002
Antiviral indoleoxoacetyl piperazine derivatives
BRISTOL MYERS SQUIBB CO96 citations95
US9879046B2Jan 30, 2018
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
BRISTOL MYERS SQUIBB CO17 citations93
US7994171B2Aug 9, 2011
Compounds for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO20 citations92
US7473688B2Jan 6, 2009
Indolobenzazepine HCV NS5B inhibitors
BRISTOL MYERS SQUIBB CO26 citations92
US7452876B2Nov 18, 2008
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
BRISTOL MYERS SQUIBB CO21 citations92
US7348337B2Mar 25, 2008
Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
BRISTOL MYERS SQUIBB CO37 citations92
US6825201B2Nov 30, 2004
Indole, azaindole and related heterocyclic amidopiperazine derivatives
BRISTOL MYERS SQUIBB CO46 citations92
US10143746B2Dec 4, 2018
Immunomodulators
BRISTOL MYERS SQUIBB CO9 citations84
US9850225B2Dec 26, 2017
Compounds useful as immunomodulators
BRISTOL MYERS SQUIBB CO13 citations84
US8048887B2Nov 1, 2011
Compounds for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO17 citations84
US7547690B2Jun 16, 2009
Compounds for the treatment of Hepatitis C
BRISTOL MYERS SQUIBB CO8 citations84
US7541353B2Jun 2, 2009
Compounds for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO11 citations84
US7538102B2May 26, 2009
Compounds for the treatment of Hepatitis C
BRISTOL MYERS SQUIBB CO16 citations84
US7521441B2Apr 21, 2009
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
BRISTOL MYERS SQUIBB CO18 citations84
US7521444B2Apr 21, 2009
Compounds for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO17 citations84
US10538555B2Jan 21, 2020
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
BRISTOL MYERS SQUIBB CO8 citations83
US8871771B2Oct 28, 2014
Salts of prodrugs of piperazine and substituted piperidine antiviral agents
BRISTOL MYERS SQUIBB CO5 citations83
US9850283B2Dec 26, 2017
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
BRISTOL MYERS SQUIBB CO12 citations82
US11578054B2Feb 14, 2023
Compounds useful as immunomodulators
BRISTOL MYERS SQUIBB CO2 citations73
US11046675B2Jun 29, 2021
Substituted isoquionline derivatives as immunomudulators
BRISTOL MYERS SQUIBB CO4 citations73
US10144706B2Dec 4, 2018
Compounds useful as immunomodulators
BRISTOL MYERS SQUIBB CO7 citations73
US10882844B2Jan 5, 2021
Compounds useful as immunomodulators
BRISTOL MYERS SQUIBB CO4 citations72
US9738653B2Aug 22, 2017
Fused furans for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO3 citations72
US9096580B2Aug 4, 2015
Benzofuran derivatives for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO3 citations63
US7998951B2Aug 16, 2011
HCV NS5B inhibitors
BRISTOL MYERS SQUIBB CO2 citations63
US10745382B2Aug 18, 2020
Compounds useful as immunomodulators
BRISTOL MYERS SQUIBB CO2 citations62
US10590105B2Mar 17, 2020
1,3-dihydroxy-phenyl derivatives useful as immunomodulators
BRISTOL MYERS SQUIBB CO2 citations62
US8722688B2May 13, 2014
Compounds for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO2 citations62
US7652004B2Jan 26, 2010
Compounds for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO4 citations62
US8039486B2Oct 18, 2011
Indole, azaindole and related heterocyclic N-substituted piperazine derivatives
BRISTOL MYERS SQUIBB CO3 citations61
US7915283B2Mar 29, 2011
Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
BRISTOL MYERS SQUIBB CO3 citations61
US11414418B2Aug 16, 2022
Compounds useful as immunomodulators
BRISTOL MYERS SQUIBB CO0 citations52
US9556162B2Jan 31, 2017
Compound for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO0 citations52
US9303020B2Apr 5, 2016
Compounds for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO1 citations52
US8354410B2Jan 15, 2013
Compounds for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO1 citations52
US11161837B2Nov 2, 2021
Benzofuran derivatives for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO0 citations47
YEUNG KAP-SUN
4 patentsUS8309558B2Nov 13, 2012
Compounds for the treatment of hepatitis C
YEUNG KAP-SUN5 citations72
US8445497B2May 21, 2013
Compounds for the treatment of hepatitis C
YEUNG KAP-SUN2 citations61
US8148382B2Apr 3, 2012
Compounds for the treatment of hepatitis C
YEUNG KAP-SUN2 citations61
US8507683B2Aug 13, 2013
Compounds for the treatment of hepatitis C
YEUNG KAP-SUN2 citations60
PRACITTO RICHARD
3 patentsUEDA YASUTSUGU
2 patentsBRISTOL MYERS SQIBB COMPANY
1 patentVIIV HEALTHCARE UK NO 4 LTD
1 patentKIM KYOUNG S
1 patentShowing the top 50 of 54 patents by PatentIndex Score.